KRAS and neoplasm: The baseline model without inclusion of 3D-QAM (model A) yielded tumor diameter [OR 1.11 (CI 1.05, 1.18)] and KRAS mutation [OR 0.29 (CI 0.09, 0.97)] as statistically significant factors affecting ASR.